Danielj Fulop News Today

Perichemotherapy antibiotics appeared associated with longer survival among patients with metastatic pancreatic ductal adenocarcinoma treated with gemcitabine, according to retrospective study results.Researchers did not observe the same benefit among patients treated with fluorouracil.

Receipt of perichemotherapy antibiotics correlated with improved survival in patients with metastatic pancreatic ductal adenocarcinoma treated with gemcitabine, but not fluorouracil, according to results in JAMA Network Open.“The rapid development of multifactorial resistance to chemotherapy is an important contributor to the dismal prognosis in pancreatic ductal adenocarcinoma